Department of Anesthesiology & Perioperative Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN.
Department of Cardiovascular Surgery, Mayo Clinic College of Medicine and Science, Rochester, MN.
J Cardiothorac Vasc Anesth. 2023 Jul;37(7):1188-1194. doi: 10.1053/j.jvca.2023.02.012. Epub 2023 Feb 11.
This study examined the postoperative analgesic efficacy of single-injection pectoral fascial plane (PECS) II blocks compared to paravertebral blocks for elective robotic mitral valve surgery.
A single-center retrospective study that reported patient and procedural characteristics, postoperative pain scores, and postoperative opioid use for patients undergoing robotic mitral valve surgery.
This investigation was performed at a large quaternary referral center.
Adult patients (age ≥18) admitted to the authors' hospital from January 1, 2016, to August 14, 2020, for elective robotic mitral valve repair who received either a paravertebral or PECS II block for postoperative analgesia.
Patients received an ultrasound-guided, unilateral paravertebral or PECS II nerve block.
One hundred twenty-three patients received a PECS II block, and 190 patients received a paravertebral block during the study period. The primary outcome measures were average postoperative pain scores and cumulative opioid use. Secondary outcomes included hospital and intensive care unit lengths of stay, need for reoperation, need for antiemetics, surgical wound infection, and atrial fibrillation incidence. Patients receiving the PECS II block required significantly fewer opioids in the immediate postoperative period than the paravertebral block group, and had comparable postoperative pain scores. No increase in adverse outcomes was noted for either group.
The PECS II block is a safe and highly effective option for regional analgesia for robotic mitral valve surgery, with demonstrated efficacy comparable to the paravertebral block.
本研究比较了单次注射胸肌筋膜平面(PECS)II 阻滞与椎旁阻滞在择期机器人二尖瓣手术中的术后镇痛效果。
这是一项单中心回顾性研究,报告了行机器人二尖瓣手术患者的患者和手术特征、术后疼痛评分和术后阿片类药物使用情况。
该调查在一家大型四级转诊中心进行。
2016 年 1 月 1 日至 2020 年 8 月 14 日期间因择期机器人二尖瓣修复术入住作者医院的成年患者(年龄≥18 岁),接受单侧椎旁或 PECS II 阻滞用于术后镇痛。
患者接受超声引导下的单侧椎旁或 PECS II 神经阻滞。
在研究期间,123 例患者接受了 PECS II 阻滞,190 例患者接受了椎旁阻滞。主要结局指标是平均术后疼痛评分和累积阿片类药物使用量。次要结局包括住院和重症监护病房的住院时间、再次手术的需要、止吐药的需要、手术部位感染和心房颤动的发生率。与椎旁阻滞组相比,接受 PECS II 阻滞的患者在术后即刻需要的阿片类药物明显较少,且术后疼痛评分相当。两组均未发现不良结局增加。
PECS II 阻滞是机器人二尖瓣手术区域镇痛的一种安全且非常有效的选择,其疗效与椎旁阻滞相当。